Anderson, Annaliesa Sybil,Ruppen, Mark E.,Jansen, Kathrin Ute,Moran, Justin Keith,Hoiseth, Susan Kay
申请号：
AU2016228316
公开号：
AU2016228316B2
申请日:
2016.09.19
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016228316B220170615.pdf#####H: dxB navv2veroaRPorthl DCCRBR I325314_11ox-14/09/206 ABSTRACT In one aspect, the invention relates to an isolated polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 71. In another 5 aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.WO 20131132452 PCT!1IB201t3/051 791 23/24 a 00C) ~l 0c)R U): r~t r-C F_ >； <； g g T77h M -- - -<； viiiiW l f；； >；>；0 ) 0- c -01- (-E- -i Ei EA - -i w F4 4 -q 4 - - 4 -q V:1 4 4 4 4 ,) cn U)E - -U ) E- P P P I X110 0 0~ CA H H H HH F0 w
